Home workouts aim to stop falls in blood cancer patients
NCT ID NCT07044427
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at why multiple myeloma patients fall and tests a personalized home exercise program to prevent falls. Sixty patients will do strength and balance exercises three times a week for six months, plus treadmill training. The goal is to see if the program is practical and reduces fear of falling.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Strength and balance training plus treadmill-based perturbation training
- What this could lead to
- If successful, this could provide a simple, home-based exercise program to reduce falls and improve quality of life for multiple myeloma patients.
- What could go wrong
- This is a small, early feasibility study with only 60 participants. The exercise program may be too demanding for some patients, and results may not apply to all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BALANCE TRAINING EFFECTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Heidelberg
RECRUITINGHeidelberg, Baden Würtemberg, 69120, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact